Top Clinical Trials companies in Sweden by EBITDA Margin

This ranking features the top 18 Clinical Trials companies in Sweden ranked by EBITDA Margin, averaging a EBITDA Margin of 2,330.08%, for January 15, 2025.

Sweden

Clinical Trials

#	Name	EBITDA Margin	Reported Date	Stock Price	Change	Country
1	OncoZenge AB (publ) 1 ONCOZ.ST	242,200.00%	Dec. 31, 2023	USD 0.45	23.08%	Sweden
2	BioArctic AB (publ) 2 BIOA-B.ST	47.94%	Dec. 31, 2023	USD 17.87	3.09%	Sweden
3	Corline Biomedical AB 3 CLBIO.ST	-6.74%	Dec. 31, 2023	USD 0.84	-0.17%	Sweden
4	Elicera Therapeutics AB (publ) 4 ELIC.ST	-152.13%	Dec. 31, 2023	USD 0.23	11.53%	Sweden
5	Mendus AB (publ) 5 IMMU.ST	-343.48%	Dec. 31, 2023	USD 0.71	-2.02%	Sweden
6	Aptahem AB (publ) 6 APTA.ST	-380.49%	Dec. 31, 2023	USD 0.11	1.51%	Sweden
7	NextCell Pharma AB 7 NXTCL.ST	-384.31%	Aug. 31, 2024	USD 0.22	-6.29%	Sweden
8	BioInvent International AB (publ) 8 BINV.ST	-437.59%	Dec. 31, 2023	USD 2.74	1.67%	Sweden
9	Hansa Biopharma AB (publ) 9 HNSA.ST	-532.88%	Dec. 31, 2023	USD 2.91	-2.20%	Sweden
10	Pila Pharma AB (publ) 10 PILA.ST	-602.35%	Dec. 31, 2023	USD 0.39	2.53%	Sweden
11	CombiGene AB (publ) 11 COMBI.ST	-637.36%	Dec. 31, 2023	USD 0.21	0.68%	Sweden
12	Clinical Laserthermia Systems AB (publ) 12 CLS-B.ST	-826.86%	Dec. 31, 2023	USD 0.28	-7.61%	Sweden
13	Prostatype Genomics AB (publ) 13 PROGEN.ST	-2,803.83%	Dec. 31, 2023	USD 0.80	0.68%	Sweden
14	IRLAB Therapeutics AB (publ) 14 IRLAB-A.ST	-3,052.55%	Dec. 31, 2023	USD 0.90	9.88%	Sweden
15	Isofol Medical AB (publ) 15 ISOFOL.ST	-5,135.09%	Dec. 31, 2023	USD 0.20	1.12%	Sweden
16	Kancera AB (publ) 16 KAN.ST	-5,979.61%	Dec. 31, 2023	USD 0.10	0.68%	Sweden
17	Lipum AB (publ) 17 LIPUM.ST	-70,035.85%	Dec. 31, 2023	USD 1.17	-3.73%	Sweden
18	Diamyd Medical AB (publ) 18 DMYD-B.ST	-108,995.38%	Aug. 31, 2024	USD 1.61	0.34%	Sweden

Frequently Asked Questions

Which Clinical Trials company in Sweden has the highest EBITDA Margin ?

The Clinical Trials company in Sweden with the highest EBITDA Margin is OncoZenge AB (publ) (Stockholm Stock Exchange: ONCOZ.ST) at 242,200.00%.
Which Clinical Trials company in Sweden has the lowest EBITDA Margin ?

The Clinical Trials company in Sweden with the lowest EBITDA Margin is Diamyd Medical AB (publ) (Stockholm Stock Exchange: DMYD-B.ST) at -108,995.38%.

What are the top 10 Clinical Trials companies in Sweden by EBITDA Margin ?

The top 10 Clinical Trials companies in Sweden by EBITDA Margin are OncoZenge AB (publ), BioArctic AB (publ), Corline Biomedical AB, Elicera Therapeutics AB (publ), Mendus AB (publ), Aptahem AB (publ), NextCell Pharma AB, BioInvent International AB (publ), Hansa Biopharma AB (publ) and Pila Pharma AB (publ).
What are the bottom 10 Clinical Trials companies in Sweden by EBITDA Margin ?

The bottom 10 Clinical Trials companies in Sweden by EBITDA Margin are Diamyd Medical AB (publ), Lipum AB (publ), Kancera AB (publ), Isofol Medical AB (publ), IRLAB Therapeutics AB (publ), Prostatype Genomics AB (publ), Clinical Laserthermia Systems AB (publ), CombiGene AB (publ), Pila Pharma AB (publ) and Hansa Biopharma AB (publ).